title: Reply to 'The challenge to one course carboplatin in seminoma clinical stage 1' by Dieckmann and Anheuser.
authors.affiliation: The Cancer Clinic, St Olavs Hospital, Trondheim, Norway torgrim.tandstad@stolav.no.
authors.forename: T
authors.initials: T
authors.lastname: Tandstad
authors.affiliation: Department of Oncology-Pathology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Cohn-Cedermark
mesh_terms: D000970:Antineoplastic Agents; D016190:Carboplatin; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy; D018239:Seminoma; D013736:Testicular Neoplasms
chemical_list: D000970:Antineoplastic Agents; D016190:Carboplatin